van Beek, Nina; Dähnrich, Cornelia; Johannsen, Nora; Lemcke, Susanne; Goletz, Stephanie; Hübner, Franziska; Di Zenzo, Giovanni; Dmochowski, Marian; Drenovska, Kossara; Geller, Shamir; Horn, Michael Peter; Kowalewski, Cezary; Medenica, Ljiljana; Murrell, Dedee F; Patsatsi, Aikaterini; Uzun, Soner; Vassileva, Snejina; Zillikens, Detlef; Schlumberger, Wolfgang and Schmidt, Enno (2017). Prospective studies on the routine use of a novel multivariant enzyme-linked immunosorbent assay for the diagnosis of autoimmune bullous diseases. Journal of the American Academy of Dermatology, 76(5), 889-894.e5. Elsevier 10.1016/j.jaad.2016.11.002
Text
1-s2.0-S019096221631043X-main-1.pdf - Published Version Restricted to registered users only Available under License Publisher holds Copyright. Download (662kB) |
BACKGROUND
Serologic diagnosis of autoimmune blistering disease (AIBD) usually follows a sophisticated multistep algorithm.
OBJECTIVE
We sought validation of a multivariant enzyme-linked immunosorbent assay (ELISA) in the routine diagnosis of AIBD.
METHODS
The multivariant ELISA comprising 6 recombinant immunodominant forms of major AIBD target antigens, ie, desmoglein 1, desmoglein 3, envoplakin, BP180, BP230, and type VII collagen was applied in: (1) a cohort of well-characterized AIBD (n = 173) and control sera (n = 130), (2) a prospective multicenter study with 204 sera from patients with newly diagnosed AIBD with positive direct immunofluorescence microscopy, and (3) a prospective monocenter study with 292 consecutive sera from patients with clinical suspicion of AIBD in comparison with the conventional multistep diagnostic algorithm.
RESULTS
Concordant results in the multivariant ELISA compared with direct immunofluorescence microscopy were seen in 94% of patients with pemphigus and 71% of patients with pemphigoid (Cohen κ value, 0.95 and 0.66) and with the conventional multistep diagnostic approach in 91% of patients with pemphigus and 88% of patients with bullous pemphigoid and 93% of autoantibody-negative sera (Cohen κ, 0.95, 0.84, and 0.78).
LIMITATIONS
IgA autoantibodies and less common target antigens were not analyzed.
CONCLUSIONS
The multivariant ELISA is a practical, highly standardized, and widely available novel diagnostic tool for the routine diagnosis of AIBD.
Item Type: |
Journal Article (Original Article) |
---|---|
Division/Institute: |
04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Institute of Clinical Chemistry |
UniBE Contributor: |
Horn, Michael Peter |
Subjects: |
600 Technology > 610 Medicine & health |
ISSN: |
0190-9622 |
Publisher: |
Elsevier |
Language: |
English |
Submitter: |
Marie-Christine Müller |
Date Deposited: |
18 Apr 2017 14:37 |
Last Modified: |
05 Dec 2022 15:02 |
Publisher DOI: |
10.1016/j.jaad.2016.11.002 |
PubMed ID: |
28038887 |
Uncontrolled Keywords: |
autoantibody; blistering; bullous pemphigoid; epidermolysis bullosa acquisita; pemphigus |
BORIS DOI: |
10.7892/boris.95555 |
URI: |
https://boris.unibe.ch/id/eprint/95555 |